Kwong Ng

734 total citations
36 papers, 494 citations indexed

About

Kwong Ng is a scholar working on Economics and Econometrics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Kwong Ng has authored 36 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Kwong Ng's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Pharmaceutical Economics and Policy (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Kwong Ng is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Pharmaceutical Economics and Policy (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Kwong Ng collaborates with scholars based in Singapore, Taiwan and United Kingdom. Kwong Ng's co-authors include Shuu‐Jiun Wang, Fiona Pearce, Chao‐Hsiun Tang, Liang Lin, Jong‐Ling Fuh, Kuan‐Po Peng, Lee Cheng Phua, Soo Chin Lee, David Bin‐Chia Wu and Wan‐Teck Lim and has published in prestigious journals such as PLoS ONE, Vaccine and BMC Cancer.

In The Last Decade

Kwong Ng

33 papers receiving 485 citations

Peers

Kwong Ng

PMH

ONCOL

PRM

PFM

PHYSI

M Benford United Kingdom

Vamsi Bollu United States

Nicola Bonner United Kingdom

J. Nicklin United Kingdom

Jennifer Eriksson United Kingdom

Kari Anderson United States

Ruchit Shah United States

Shien Guo United States

Soumya Sundaram India

Samuel Knauß Germany

M Benford United Kingdom

Kwong Ng

59 ×0.4

PMH

65 ×0.6

ONCOL

97 ×0.9

PRM

54 ×0.6

PFM

68 ×0.9

PHYSI

Citations per year, relative to Kwong Ng Kwong Ng (= 1×) peers M Benford

Countries citing papers authored by Kwong Ng

Since Specialization

Citations

This map shows the geographic impact of Kwong Ng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kwong Ng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kwong Ng more than expected).

Fields of papers citing papers by Kwong Ng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kwong Ng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kwong Ng. The network helps show where Kwong Ng may publish in the future.

Co-authorship network of co-authors of Kwong Ng

This figure shows the co-authorship network connecting the top 25 collaborators of Kwong Ng. A scholar is included among the top collaborators of Kwong Ng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kwong Ng. Kwong Ng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wong, Wei, et al.. (2025). Cost-effectiveness analysis of trastuzumab emtansine for second-line treatment of HER2+ advanced breast cancer in Singapore. Expert Review of Pharmacoeconomics & Outcomes Research. 25(5). 679–687.

Goh, Louise Gek Huang, et al.. (2024). Impact of Value-Driven Healthcare Strategies for Biosimilar Adoption: The Singapore Story. PharmacoEconomics - Open. 8(5). 679–688. 2 indexed citations

Kearns, Benjamin, et al.. (2022). Cost-effectiveness of transcatheter aortic valve implantation in patients with severe symptomatic aortic stenosis of intermediate surgical risk in Singapore. BMC Health Services Research. 22(1). 994–994. 2 indexed citations

Shiroiwa, Takeru, Jeonghoon Ahn, Xue Li, et al.. (2022). Developing a New Region-Specific Preference-Based Measure in East and Southeast Asia. Value in Health Regional Issues. 32. 62–69. 4 indexed citations

Goh, Louise Gek Huang, et al.. (2022). Real-world evaluation of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors for managing type 2 diabetes mellitus: a retrospective multi-ethnic cohort study. Journal of Diabetes & Metabolic Disorders. 21(1). 521–555. 5 indexed citations

Phua, Lee Cheng, Cheuk‐Wai Choi, Joseph T. Wu, et al.. (2021). Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore. Vaccine. 39(16). 2255–2263. 9 indexed citations

Tan, Cher Heng, et al.. (2021). Cost-effectiveness of MRI targeted biopsy strategies for diagnosing prostate cancer in Singapore. BMC Health Services Research. 21(1). 909–909. 3 indexed citations

Ng, Kwong, et al.. (2021). A review of implementation frameworks to operationalize health technology assessment recommendations for medical technologies in the Singapore setting. International Journal of Technology Assessment in Health Care. 37(1). e56–e56. 4 indexed citations

Lee, Soo Chin, et al.. (2020). Cost‐effectiveness of ribociclib as initial treatment for premenopausal women with advanced breast cancer in Singapore. Cancer Reports. 4(1). e1308–e1308. 6 indexed citations

10.

Toh, Chee‐Keong, et al.. (2020). Cost-effectiveness analysis of pembrolizumab monotherapy versus chemotherapy for previously untreated advanced non-small cell lung cancer. Journal of Medical Economics. 23(9). 952–960. 16 indexed citations

11.

Koh, Mariko Siyue, et al.. (2020). Assessing the cost-effectiveness of mepolizumab as add-on therapy to standard of care for severe eosinophilic asthma in Singapore. Journal of Asthma. 59(1). 189–199. 17 indexed citations

12.

Lin, Liang, et al.. (2020). Towards greater impact in health technology assessment: horizon scanning for new and emerging technologies in Singapore. International Journal of Technology Assessment in Health Care. 36(4). 304–310. 4 indexed citations

13.

Pearce, Fiona, et al.. (2019). Cost-Effectiveness Analysis of Sunitinib versus Interferon-Alfa for First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma in Singapore. International Journal of Technology Assessment in Health Care. 35(2). 126–133. 11 indexed citations

14.

Wu, David Bin‐Chia, et al.. (2019). Cost-effectiveness analysis of bilateral cochlear implants for children with severe-to-profound sensorineural hearing loss in both ears in Singapore. PLoS ONE. 14(8). e0220439–e0220439. 16 indexed citations

15.

Pearce, Fiona, et al.. (2018). Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis. International Journal of COPD. Volume 13. 3203–3231. 35 indexed citations

16.

Pearce, Fiona, et al.. (2018). Health Technology Assessment and Its Use in Drug Policies: Singapore. Value in Health Regional Issues. 18. 176–183. 22 indexed citations

17.

Lee, Kyu Sung, Ju Tae Seo, Seung‐June Oh, et al.. (2015). Impact of overactive bladder on quality of life and resource use: results from Korean Burden of Incontinence Study (KOBIS). Health and Quality of Life Outcomes. 13(1). 89–89. 26 indexed citations

18.

Wang, Mengting, et al.. (2013). Analysis of Excess Direct Medical Costs of Vision Impairment in Taiwan. Value in Health Regional Issues. 2(1). 57–63. 2 indexed citations

19.

Lai, Edward Chia‐Cheng, Yea‐Huei Kao Yang, Hann‐Chorng Kuo, Kwong Ng, & Emily Cheng. (2012). Management of Neurogenic Detrusor Overactivity in Patients with Spinal Cord Injury in Taiwan. Pharmacoepidemiology and Drug Safety. 21. 64–65. 1 indexed citations

20.

Lai, Edward Chia‐Cheng, Yea‐Huei Kao Yang, Hann‐Chorng Kuo, Kwong Ng, & Emily Cheng. (2012). Prevalence of Neurogenic Detrusor Overactivity associated with Spinal Cord Injury in Taiwan. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact